Tyra Biosciences Announces Participation in Upcoming Healthcare Investor Conferences
Tyra Biosciences (Nasdaq: TYRA) has announced its upcoming participation in two major investor conferences scheduled for November 2026. The company will engage in one-on-one meetings at the Guggenheim 3rd Annual Healthcare Innovation Conference in Boston on November 10, followed by a hybrid presentation and individual meetings at the Jefferies Global Healthcare Conference in London on November 16. The clinical-stage biotechnology firm is focused on precision medicines targeting Fibroblast Growth Factor Receptor (FGFR) biology. This series of investor engagements provides an opportunity for the company to present updates regarding its SNÅP platform and its pipeline of candidates, including dabogratinib, TYRA-430, and TYRA-200.
Tickers: $TYRA
Topics: biotechnology clinical-stage company investor relations
Read the full article at PR Newswire
Part of the story MSA Safety Announces Participation in November Investor Conferences (4 articles)